A Cost-Utility Analysis of Prosigna®, A 50 Gene Test for Predicting Breast Cancer Recurrence, in the Australian Setting
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.128
https://www.valueinhealthjournal.com/article/S1098-3015(18)32485-9/fulltext
Title :
A Cost-Utility Analysis of Prosigna®, A 50 Gene Test for Predicting Breast Cancer Recurrence, in the Australian Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32485-9&doi=10.1016/j.jval.2018.07.128
First page :
Section Title :
Open access? :
No
Section Order :
130